| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 348 | 952 | 11.716 | 12.542 | 7.731 | 13.303 |
| Total Income - EUR | - | - | - | - | 348 | 952 | 11.716 | 12.542 | 7.731 | 13.355 |
| Total Expenses - EUR | - | - | - | - | 1.558 | 3.723 | 8.310 | 9.038 | 9.620 | 13.459 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.210 | -2.771 | 3.406 | 3.504 | -1.888 | -105 |
| Net Profit/Loss - EUR | - | - | - | - | -1.220 | -2.799 | 3.115 | 3.284 | -1.966 | -105 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Clar Nutripharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 70 | 69 | 708 | 304 | 0 | 0 |
| Current Assets | - | - | - | - | 1.912 | 348 | 4.356 | 8.335 | 7.404 | 6.781 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 72 | 582 | 624 | 867 | 1.344 |
| Cash | - | - | - | - | 1.912 | 276 | 3.774 | 7.712 | 6.537 | 5.437 |
| Shareholders Funds | - | - | - | - | -1.178 | -3.955 | -752 | 2.529 | 556 | 449 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.161 | 4.372 | 5.815 | 6.110 | 6.848 | 6.332 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Clar Nutripharm S.r.l.